WO2024014012A1 - Système de gestion centrale d'informations de santé / médicales - Google Patents
Système de gestion centrale d'informations de santé / médicales Download PDFInfo
- Publication number
- WO2024014012A1 WO2024014012A1 PCT/JP2022/047347 JP2022047347W WO2024014012A1 WO 2024014012 A1 WO2024014012 A1 WO 2024014012A1 JP 2022047347 W JP2022047347 W JP 2022047347W WO 2024014012 A1 WO2024014012 A1 WO 2024014012A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- information
- health
- medical
- management system
- incentive
- Prior art date
Links
- 230000036541 health Effects 0.000 title claims abstract description 503
- 238000009825 accumulation Methods 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims description 97
- 238000012545 processing Methods 0.000 claims description 85
- 238000007876 drug discovery Methods 0.000 claims description 10
- 238000003672 processing method Methods 0.000 claims description 10
- 230000001276 controlling effect Effects 0.000 claims description 9
- 238000011160 research Methods 0.000 claims description 7
- 235000013305 food Nutrition 0.000 claims description 5
- 238000001467 acupuncture Methods 0.000 claims description 3
- 230000002079 cooperative effect Effects 0.000 claims description 3
- 239000003337 fertilizer Substances 0.000 claims description 3
- 230000005180 public health Effects 0.000 claims description 3
- 238000005070 sampling Methods 0.000 claims description 3
- 230000006870 function Effects 0.000 description 93
- 238000010586 diagram Methods 0.000 description 88
- 239000003814 drug Substances 0.000 description 84
- 229940079593 drug Drugs 0.000 description 57
- 230000008569 process Effects 0.000 description 48
- 230000000875 corresponding effect Effects 0.000 description 23
- 238000012360 testing method Methods 0.000 description 23
- 238000004891 communication Methods 0.000 description 20
- 210000002700 urine Anatomy 0.000 description 18
- 238000004364 calculation method Methods 0.000 description 17
- 238000010079 rubber tapping Methods 0.000 description 17
- 238000011282 treatment Methods 0.000 description 15
- 230000000474 nursing effect Effects 0.000 description 13
- 230000000694 effects Effects 0.000 description 12
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 230000036772 blood pressure Effects 0.000 description 8
- 230000036760 body temperature Effects 0.000 description 8
- 238000001356 surgical procedure Methods 0.000 description 8
- OBHRVMZSZIDDEK-UHFFFAOYSA-N urobilinogen Chemical compound CCC1=C(C)C(=O)NC1CC1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(CC3C(=C(CC)C(=O)N3)C)N2)CCC(O)=O)N1 OBHRVMZSZIDDEK-UHFFFAOYSA-N 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 6
- 230000014759 maintenance of location Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 230000008774 maternal effect Effects 0.000 description 5
- 230000002093 peripheral effect Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 208000035473 Communicable disease Diseases 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- 210000000577 adipose tissue Anatomy 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 4
- 230000007815 allergy Effects 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 239000003168 generic drug Substances 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000012797 qualification Methods 0.000 description 4
- 238000012552 review Methods 0.000 description 4
- 230000004622 sleep time Effects 0.000 description 4
- 230000007704 transition Effects 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 150000002826 nitrites Chemical class 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000036387 respiratory rate Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 208000001528 Coronaviridae Infections Diseases 0.000 description 2
- 206010013710 Drug interaction Diseases 0.000 description 2
- 208000032928 Dyslipidaemia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000017170 Lipid metabolism disease Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 208000030533 eye disease Diseases 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000003862 health status Effects 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 230000004630 mental health Effects 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 230000032696 parturition Effects 0.000 description 2
- 208000028169 periodontal disease Diseases 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 235000009849 Cucumis sativus Nutrition 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000010827 pathological analysis Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000004800 psychological effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000013403 standard screening design Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
Abstract
L'invention fournit un système de gestion centrale d'informations de santé / médicales qui, par rapport à l'approbation / au refus de publication d'informations de santé / médicales d'individus, incite un individu à favoriser la gestion centrale des informations de santé / médicales. Un système de gestion centrale d'informations de santé / médicales est fourni, comprenant : une unité d'accumulation d'informations de santé / médicales dans laquelle des informations de santé / médicales associées à des individus sont accumulées pour une gestion centrale ; une unité de commande d'accès pour commander la divulgation des informations de santé / médicales accumulées dans l'unité d'accumulation d'informations de santé / médicales à un tiers par l'intermédiaire d'un réseau ; et une unité de fonction d'incitation qui, par rapport à l'approbation / au refus de publication d'informations de santé / médicales d'individus, comprend au moins une unité de gestion d'incitation pour inciter un individu à favoriser la gestion centrale des informations de santé / médicales.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022-113728 | 2022-07-15 | ||
JP2022113728A JP2024011594A (ja) | 2022-07-15 | 2022-07-15 | 健康医療情報一元管理システム |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024014012A1 true WO2024014012A1 (fr) | 2024-01-18 |
Family
ID=89536292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2022/047347 WO2024014012A1 (fr) | 2022-07-15 | 2022-12-22 | Système de gestion centrale d'informations de santé / médicales |
Country Status (2)
Country | Link |
---|---|
JP (2) | JP2024011594A (fr) |
WO (1) | WO2024014012A1 (fr) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140136237A1 (en) * | 2012-11-13 | 2014-05-15 | Nicholas G. Anderson | Healthcare data management system |
US20140244309A1 (en) * | 2011-11-08 | 2014-08-28 | Revon Systems, Llc | Systems and methods for assembling electronic medical records |
WO2015040713A1 (fr) * | 2013-09-19 | 2015-03-26 | 株式会社日立製作所 | Dispositif, système et procédé de collecte de données d'utilisateur de médicament |
JP2018514831A (ja) * | 2015-03-09 | 2018-06-07 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | ウェアラブル技術センサデータ共有の動機付け |
WO2020257647A1 (fr) * | 2019-06-19 | 2020-12-24 | Electronic Health Record Data, Inc. | Système et procédé de chaîne de blocs de données de dossier médical électronique |
WO2021130489A1 (fr) * | 2019-12-24 | 2021-07-01 | Geromics Ltd | Procédé et système d'attestation numérique |
JP2022025166A (ja) * | 2020-07-29 | 2022-02-10 | Advanced Medical InfoTec株式会社 | 情報システム |
-
2022
- 2022-07-15 JP JP2022113728A patent/JP2024011594A/ja active Pending
- 2022-12-22 WO PCT/JP2022/047347 patent/WO2024014012A1/fr unknown
-
2023
- 2023-10-02 JP JP2023171410A patent/JP2024012205A/ja active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140244309A1 (en) * | 2011-11-08 | 2014-08-28 | Revon Systems, Llc | Systems and methods for assembling electronic medical records |
US20140136237A1 (en) * | 2012-11-13 | 2014-05-15 | Nicholas G. Anderson | Healthcare data management system |
WO2015040713A1 (fr) * | 2013-09-19 | 2015-03-26 | 株式会社日立製作所 | Dispositif, système et procédé de collecte de données d'utilisateur de médicament |
JP2018514831A (ja) * | 2015-03-09 | 2018-06-07 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | ウェアラブル技術センサデータ共有の動機付け |
WO2020257647A1 (fr) * | 2019-06-19 | 2020-12-24 | Electronic Health Record Data, Inc. | Système et procédé de chaîne de blocs de données de dossier médical électronique |
WO2021130489A1 (fr) * | 2019-12-24 | 2021-07-01 | Geromics Ltd | Procédé et système d'attestation numérique |
JP2022025166A (ja) * | 2020-07-29 | 2022-02-10 | Advanced Medical InfoTec株式会社 | 情報システム |
Also Published As
Publication number | Publication date |
---|---|
JP2024011594A (ja) | 2024-01-25 |
JP2024012205A (ja) | 2024-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
O’Leary et al. | Patients’ and healthcare providers’ perceptions of a mobile portal application for hospitalized patients | |
Curry | eHealth research and healthcare delivery: Beyond intervention effectiveness | |
US20120239432A1 (en) | Method and system for healthcare information data storage | |
Serrano et al. | Does the primary care behavioral health model reduce emergency department visits? | |
Helmer et al. | Empowering patients through personal health records: A survey of existing third-party web-based PHR products | |
Müller et al. | Integration of mobile sensors in a telemedicine hospital system: remote-monitoring in COVID-19 patients | |
WO2023120702A1 (fr) | Système de partage d'informations de soins de santé | |
Okoniewska et al. | The Seamless Transfer-of-Care Protocol: a randomized controlled trial assessing the efficacy of an electronic transfer-of-care communication tool | |
WO2024014012A1 (fr) | Système de gestion centrale d'informations de santé / médicales | |
JP7232436B1 (ja) | 共有健康医療情報第三者開示システム | |
JP7133136B1 (ja) | 共有健康医療情報第三者開示システム | |
JP7204271B1 (ja) | 共有健康医療情報第三者開示システム | |
JP7187089B1 (ja) | 健康医療情報共有システム | |
Donaldson | Using patient-reported outcomes in clinical oncology practice: benefits, challenges and next steps | |
JP7421251B1 (ja) | リスク判定システム | |
JP2022006681A (ja) | 電子カルテシステム、電子カルテシステムの処理方法及びプログラム | |
Ross et al. | Increasing access to safe medical cannabis | |
McFadden et al. | Development of a web-based registry to support diabetes care in free medical clinics | |
Grain | Changes in doctor-patient relationships for realizing the personal health paradigm | |
Sawarkar et al. | An Android Application for Electronic Health Record System | |
Zuckerman et al. | Personal health records | |
Kern et al. | Active patient role in recording health data | |
Burton-Shepherd | Medicines optimisation in patients with long-term conditions | |
Aliyu et al. | WEB-BASED HOSPITAL MANAGEMENT INFORMATION SYSTEM A CASE STUDY OF IBRAHIM BADAMASI BABANGIDA UNIVERSITY HEALTH CARE CENTRE, LAPAI, NIGER STATE | |
Haghani | Reduction of Blood Pressure Among Adult Hypertensive Patients Using Remote Patient Monitoring Followed by Telehealth |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22951218 Country of ref document: EP Kind code of ref document: A1 |